Utah Medical Products UTMD Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized To Be Recognized Over The Next Four Years
Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized To Be Recognized Over The Next Four Years at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept fil:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedToBeRecognizedOverTheNextFourYears.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's employee service share based compensation nonvested awards compensation cost not yet recognized to be recognized over the next four years.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Utah Medical Products's employee service share based compensation nonvested awards compensation cost not yet recognized to be recognized over the next four years?
- Utah Medical Products (UTMD) reported employee service share based compensation nonvested awards compensation cost not yet recognized to be recognized over the next four years of $572K in Q4 2025.
- What is the long-term trend for Utah Medical Products's employee service share based compensation nonvested awards compensation cost not yet recognized to be recognized over the next four years?
- Over 2 years (2023 to 2025), Utah Medical Products's employee service share based compensation nonvested awards compensation cost not yet recognized to be recognized over the next four years has grown at a 3362.9% compound annual growth rate (CAGR), from $477 to $572K.
- What does employee service share based compensation nonvested awards compensation cost not yet recognized to be recognized over the next four years mean?
- This represents the total unrecognized compensation cost related to nonvested share-based awards that will be amortized over the next four years. It serves as a forward-looking indicator of long-term equity-based compensation expenses and talent retention costs.